Compare RVPH & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVPH | ABLV |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | United States | China |
| Employees | 14 | 89 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 36.1M |
| IPO Year | N/A | N/A |
| Metric | RVPH | ABLV |
|---|---|---|
| Price | $2.47 | $0.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $66.67 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 5.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.17 | $0.59 |
| 52 Week High | $3.11 | $1.77 |
| Indicator | RVPH | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 75.19 | 39.23 |
| Support Level | $0.32 | $0.60 |
| Resistance Level | N/A | $0.97 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | 0.28 | -0.01 |
| Stochastic Oscillator | 76.53 | 24.24 |
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.